Myasthenia Gravis Trial, Recruiting (NCT05214612)

Myasthenia Gravis Trial, Recruiting NCT05214612 Sponsor: Assiut University Condition: Myasthenia Gravis

Printed from Voxsanity (voxsanity.com.au) — NCT05214612 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Myasthenia Gravis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are 16 years old or older
You are any gender — both males and females are welcome
You have been diagnosed with Myasthenia Gravis (MG), a condition that causes muscle weakness, supported by at least one of the following: your symptoms clearly improved when taking a medication called pyridostigmine, OR a specific nerve test (called repetitive nerve stimulation) showed a certain level of abnormal result
You are willing to provide samples (such as blood), undergo imaging scans, and take part in other tests and assessments related to the condition

Who may not be able to join:

You are younger than 16 years old
You have a long-term psychiatric (mental health) or neurological (brain or nerve) condition — other than MG — that can also cause muscle weakness or tiredness
You have a serious illness that is expected to significantly shorten your life expectancy

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 01063981139

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05214612

Sponsor: Assiut University

Phase: Not Applicable

Status: Recruiting

Condition: Myasthenia Gravis

Trial contact: 01063981139

More information: https://clinicaltrials.gov/study/NCT05214612

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are 16 years old or older
You are any gender — both males and females are welcome
You have been diagnosed with Myasthenia Gravis (MG), a condition that causes muscle weakness, supported by at least one of the following: your symptoms clearly improved when taking a medication called pyridostigmine, OR a specific nerve test (called repetitive nerve stimulation) showed a certain level of abnormal result
You are willing to provide samples (such as blood), undergo imaging scans, and take part in other tests and assessments related to the condition

Who may not be able to join:

You are younger than 16 years old
You have a long-term psychiatric (mental health) or neurological (brain or nerve) condition — other than MG — that can also cause muscle weakness or tiredness
You have a serious illness that is expected to significantly shorten your life expectancy

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Assiut University

Registry

ClinicalTrials.gov

Start date

1 January 2022

Est. completion

31 December 2024

Where this trial is recruiting

🇪🇬 Egypt

Primary endpoints

Change in MG-specific Activities of Daily Living scale (MG-ADL).; Change in MG quality of life 15 (MG-QOL15).; Change in MG manual muscle testing (MG-MMT).; Change in MG composite (MGC) Score.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov